Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026)
Pharma-Bio Serv posted quarterly Return on Capital Employed of 6.22% for Q1 2026, up 116.0% year-on-year from 2.88% in Q1 2025, and down 15.87% on a QoQ basis from 5.37% in Q4 2025.
Pharma-Bio Serv (PBSV) has 14 years of Return on Capital Employed data on file, last reported at 6.22% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 116.0% year-over-year to 6.22%; the trailing twelve-month figure through Jan 2026 stood at 6.22% (up 116.0% YoY), and the FY2025 full-year result was 4.82%, up 312.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 6.22%, down from 5.37% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 7.64% in Q3 2023 and bottomed at 20.97% in Q3 2022.
- The 5-year median for Return on Capital Employed is 5.45% (2025), against an average of 4.34%.
- The widest annual swing landed in 2022, when Return on Capital Employed sank 2665 bps; it then soared 2861 bps in 2023.
- A 5-year view of Return on Capital Employed shows it stood at 6.39% in 2022, then retreated by 3 bps to 6.23% in 2023, then slumped by 243 bps to 8.93% in 2024, then surged by 40 bps to 5.37% in 2025, then decreased by 16 bps to 6.22% in 2026.
- The last three Return on Capital Employed figures came in at 6.22% (Q1 2026), 5.37% (Q4 2025), and 5.45% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 13.28% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -163.65% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 21.81% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 4.73% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -4.23% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.23% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -6.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -6.22% |
| Oct 31, 2025 | -5.37% |
| Jul 31, 2025 | -5.45% |
| Apr 30, 2025 | -5.50% |
| Jan 31, 2025 | -7.38% |
| Oct 31, 2024 | -8.93% |
| Jul 31, 2024 | -8.05% |
| Apr 30, 2024 | -2.16% |
| Jan 31, 2024 | 2.21% |
| Oct 31, 2023 | 6.23% |
| Jul 31, 2023 | 7.64% |
| Apr 30, 2023 | 6.56% |
| Jan 31, 2023 | 5.79% |
| Oct 31, 2022 | 6.39% |
| Jul 31, 2022 | -20.97% |
| Apr 30, 2022 | -20.08% |
| Jan 31, 2022 | -18.46% |
| Oct 31, 2021 | -16.34% |
| Jul 31, 2021 | 4.23% |
| Apr 30, 2021 | 6.02% |
| Jan 31, 2021 | 8.19% |
| Oct 31, 2020 | 8.49% |
| Jul 31, 2020 | 9.76% |
| Apr 30, 2020 | 8.28% |
| Jan 31, 2020 | 7.37% |
| Oct 31, 2019 | 7.62% |
| Jul 31, 2019 | 7.57% |
| Apr 30, 2019 | 9.21% |
| Jan 31, 2019 | 7.22% |
| Oct 31, 2018 | -5.79% |
| Jul 31, 2018 | -7.84% |
| Apr 30, 2018 | -12.43% |
| Jan 31, 2018 | -13.72% |
| Oct 31, 2017 | -3.72% |
| Jul 31, 2017 | -6.40% |
| Apr 30, 2017 | -5.97% |
| Jan 31, 2017 | -3.92% |
| Oct 31, 2016 | -0.42% |
| Apr 30, 2013 | 40.60% |
| Jan 31, 2013 | 40.82% |
| Oct 31, 2012 | 47.57% |
| Jul 31, 2012 | 48.48% |
| Apr 30, 2012 | 49.42% |
| Jan 31, 2012 | 47.22% |
| Oct 31, 2011 | 45.18% |